Market revenue in 2023 | USD 12.7 million |
Market revenue in 2030 | USD 16.4 million |
Growth rate | 3.7% (CAGR from 2023 to 2030) |
Largest segment | Sex reassignment surgery |
Fastest growing segment | Sex Reassignment Surgery |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vaginal Agenesis Treatment Surgery, Sex Reassignment Surgery, Vaginal Atresia Treatment Surgery |
Key market players worldwide | Icahn School of Medicine at Mount Sinai, Nationwide Children's Hospital, Tricity Institute of Plastic Surgery TIPS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neovaginal surgery market will help companies and investors design strategic landscapes.
Sex reassignment surgery was the largest segment with a revenue share of 55.12% in 2023. Horizon Databook has segmented the Mexico neovaginal surgery market based on vaginal agenesis treatment surgery, sex reassignment surgery, vaginal atresia treatment surgery covering the revenue growth of each sub-segment from 2018 to 2030.
In October 2019, a study conducted to evaluate the prevalence of Müllerian Anomalies (MA) in Mexico revealed that out of the total prevalence of MA, vaginal agenesis contributed only 3.4% and septate uterus, arcuate uterus, bicornuate uterus, unicornuate uterus, and didelphys uterus were responsible for the rest.
Annually, around 100,000 international patients visit Mexican hospitals to seek remarkable medical care at significantly reduced rates. The vendors offering vaginal dilators and stents in the country have entered into agreements and partnerships with internationally accredited hospitals to help patients undergoing male-to-female gender reassignment procedures. T
he cost of these procedures is up to 80% less in comparison with the average procedure cost in the U.S., UK, and Australia without hampering procedure quality. Availability of gender reassignment procedures at a relatively low cost makes Mexico a potential key market for neovaginal surgeries.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico neovaginal surgery market , including forecasts for subscribers. This country databook contains high-level insights into Mexico neovaginal surgery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account